——Research group in Shanghai, Sep 10, 2021
——Research group in Shanghai, Sep 10, 2021
Prostate volume does not provide additional predictive value to prostate health index for prostate cancer or clinically significant prostate cancer: results from a multicenter study in China.
Huang D#, Wu Y-S#, Ye D-W, Qi J, Liu F, Helfand BT, Zheng SL, Ding Q, Xu D-F, Na R, Xu J-F, Sun Y-H. (#: Equal contribution)
Asian Journal of Andrology 2020. [PubMed] [DOI]
Family history is significantly associated with prostate cancer and its early onset in Chinese population.
Xu Y#, Huang D#, Wu Y#, Ye D#, Zhang N, Gao Y, Xu D, Na R, Xu J. (#: Equal contribution)
The Prostate 2019. [PubMed] [DOI]
Cost-effectiveness Analysis of Prostate Health Index (phi) in Decision Making for Initial Prostate Biopsy.
Huang D#, Yang X#, Wu Y, Lin X, Xu D, Na R, Xu J. (#: Equal contribution)
Frontiers in Oncology 2020. [PubMed ] [DOI]
Genome-wide Expression Analysis Identifies the Association between SEC14L2 and Castration-resistant Prostate Cancer Survival.
Liu S#, Huang D#, Huang J, Yan J, Chen T, Zhang N, Jiang G, Gao Y, Xu D, Na R. (#: Equal contribution)
Journal of Cancer 2021. [PubMed ] [DOI]
Genetic polymorphisms at 19q13.33 are associated with [-2]proPSA (p2PSA) levels and provide additional predictive value to prostate health index for prostate cancer.
Huang D#, Ruan X#, Wu Y#, Lin X, Huang J, Ye D, Gao Y, Ding Q, Xu D, Na R. (#: Equal contribution)
Prostate 2021. [PubMed ] [DOI]
Prostate Health Index (phi) and its derivatives predict Gleason score upgrading after radical prostatectomy among patients with low-risk prostate cancer.
Yan J-Q#, Huang D#, Huang J-Y, Ruan X-H, Lin X-L, Fang Z-J, Gao Y, Jiang H-W, Wu Y-S, Na R, Xu D-F. (#: Equal contribution)
Asian Journal of Andrology 2021. [PubMed ] [DOI]
A Germline Variant at 8q24 Contributes to the Serum p2PSA Level in a Chinese Prostate Biopsy Cohort.
Lin X, Wu Y, Liu F, Na R, Huang D, Xu D, Gong J, Zhu Y, Dai B, Ye D, Yu H, Jiang H, Fang Z, Zheng J, Ding Q.
Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma.
Huang J#, Huang D#, Yan J, Chen T, Gao Y, Xu D, Na R. (#: Equal contribution)
Cancer Medicine 2020. [PubMed] [DOI]
The Clinical Implications and Molecular Mechanism of CX3CL1 Expression in Urothelial Bladder Cancer.
Jiang G#, Wang H#, Huang D#, Wu Y, Ding W, Zhou Q, Ding Q, Zhang N, Na R, Xu K. (#: Equal contribution)
Gender Gap in Industry Relationships and Scholarly Impact Among Academic Urologists in the United States.
Pace NM, Maganty A, Siripong N, Lee AJ, Huang D, Bandari J, Jacobs BL, Davies BJ.
Socioeconomic factors are associated with the prognosis of Thyroid Cancer.
Li Y#, Huang D#, Wang B, Mao W, Chen X, Dong P. (#: Equal contribution)